Stocks Screener

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Rxsight Inc

RXST
Current price
51.1 USD -1.24 USD (-2.36%)
Last closed 50.66 USD
ISIN US78349D1072
Sector Healthcare
Industry Medical Devices
Exchange NASDAQ
Capitalization 1 999 219 456 USD
Yield for 12 month +112.12 %
1Y
3Y
5Y
10Y
15Y
RXST
21.11.2021 - 28.11.2021

RxSight, Inc., a commercial-stage medical device company, engages in the research and development, manufacture, and sale of light adjustable intraocular lenses (LAL) used in cataract surgery in the United States and internationally. It offers RxSight system that enables doctors to customize and enhance the visual acuity for patients after cataract surgery. The company's RxSight system includes RxSight Light Adjustable Lens, a special photosensitive material that changes shape and power. RxSight light delivery device, an office-based light treatment device that delivers UV light in a programmed pattern to modify the LAL based on the visual correction needed to achieve desired vision after cataract surgery. It primarily serves cataract doctors. The company was formerly known as Calhoun Vision, Inc. and changed its name to RxSight, Inc. in February 2017. RxSight, Inc. was incorporated in 1997 and is headquartered in Aliso Viejo, California. Address: 100 Columbia, Aliso Viejo, CA, United States, 92656

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

64.86 USD

P/E ratio

Dividend Yield

Current Year

+89 077 000 USD

Last Year

+49 005 000 USD

Current Quarter

+34 887 000 USD

Last Quarter

+29 512 000 USD

Current Year

+53 765 000 USD

Last Year

+21 328 000 USD

Current Quarter

+24 250 000 USD

Last Quarter

+20 685 000 USD

Key Figures RXST

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA -38 307 000 USD
Operating Margin TTM -23.89 %
PE Ratio
Return On Assets TTM -10.58 %
PEG Ratio
Return On Equity TTM -17.01 %
Wall Street Target Price 64.86 USD
Revenue TTM 115 177 000 USD
Book Value 6.95 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY 67.6 %
Dividend Yield
Gross Profit TTM 21 328 000 USD
Earnings per share -0.99 USD
Diluted Eps TTM -0.99 USD
Most Recent Quarter II 2024
Quarterly Earnings Growth YOY
Profit Margin -31.93 %

Dividend Analytics RXST

Dividend growth over 5 years

Continuous growth

Payout Ratio 5 years average

Dividend History RXST

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date
Forward Annual Dividend Yield
Last Split Factor
Payout Ratio
Last Split Date
Dividend Date

Stock Valuation RXST

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE 109.8901
Enterprise Value Revenue 15.4314
Price Sales TTM 17.3578
Enterprise Value EBITDA -7.7044
Price Book MRQ 7.2644

Financials RXST

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators RXST

For 52 weeks

21.14 USD 66.54 USD
50 Day MA 51.89 USD
Shares Short Prior Month 2 257 462
200 Day MA 52.65 USD
Short Ratio 5.15
Shares Short 2 193 075
Short Percent 5.8 %